Condition: Celiac Disease · Autoimmune Enteropathy · Inflammatory Bowel Diseases · Sponsor: Institut National de la Santé Et de la Recherche Médicale, France
The study focuses the mechanisms underlying the loss of intestinal homeostasis in celiac disease, refractory celiac disease and other immune diseases such as monogenic enteropathy, inflammatory bowel diseases or drug induced intestinal diseases. Mechanisms of transformation of lymphocytes leading to onset of lymphomatous complications of immune enteropathies will be investigated. Mechanisms of loss of hepatic lymphocytic homeostasis will also be assessed in liver associated diseases.
This description comes directly from the study's public registry record.
Georgia MALAMUT, MD, PhD · 33 1 58 41 41 76 · georgia.malamut@aphp.fr
Anaïs LEVESCOT, MD, PhD · 33 1 42 75 42 77 · anais.levescot@inserm.fr
Always discuss trial participation with your own doctor first.
| Hôpital Henri Mondor | Créteil, France | Not Yet Recruiting |
| Hôpital Bicêtre | Le Kremlin-Bicêtre, France | Not Yet Recruiting |
| Hôpital Saint Louis | Paris, France | Not Yet Recruiting |
| Hôpital Cochin | Paris, France | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT04280510